Abstract The degree of inflammation in auto-immune diseases such as rheumatoid arthritis is often assessed in serum and used for diagnostic and prognostic purposes. The serum levels of acute inflammatory signaling molecules (C-reactive protein and serum amyloid A) in conjunction with the important pro-inflammatory cytokines themselves may have limited utility due to several limitations. (1) […]
Quantification of “end products” of tissue destruction in inflammation may reflect convergence of cytokine and signaling pathways — implications for modern clinical chemistry.
August 1, 2013
Biomarkers